Completed Infection & Immunity Cells, Biochemistry & Physiology

Host physiology of the intracellular humoral immune response

In plain English

AI plain-English summary

Antibodies and complement proteins—immune molecules best known for patrolling the space outside cells—can also fight viruses from inside the cell, and this project aims to work out exactly how. For decades, immunologists assumed that antibodies neutralised viruses only in the bloodstream or between cells. Recent work from this lab overturned that view, showing that a protein called TRIM21 grabs antibody-coated viruses that have already entered the cell’s interior and tears them apart. The team now wants to understand the molecular machinery behind that process: how TRIM21 switches from an inactive to an active form, how it decorates viral particles with ubiquitin chains to trigger destruction, and how the exposed viral genome then alerts other sensors such as RIG-I and cGAS. They also aim to identify the unknown receptor that allows complement C3 to work inside cells, and to test whether other blood proteins that bind pathogens have similar hidden intracellular roles. This is fundamental science. It redraws the map of how the immune system works, revealing an entire layer of defence that was invisible. If the mechanisms are confirmed, they could eventually inform new antiviral strategies—for example, drugs or vaccines designed to harness intracellular antibody activity—but the immediate payoff is a deeper understanding of immunity itself.

View original technical description
Recent work from my lab has led to the discovery that antibodies and complement have important immune functions inside the cell. We now propose to establish how intracellular humoral immunity works and how it integrates with other immune pathways to promote an antiviral state. Our first objective is to determine how the cytosolic IgG receptor TRIM21 functions and is regulated. We will investigate how the catalysis of diverse ubiquitin chains confers dual TRIM21 activity. TRIM21 is widely expressed by most tissues but in an inactive form. We will use a combined cellular and biophysical approach to explain how TRIM21 is activated. TRIM21 intercepts incoming antibody-coated virions in the cytosol and causes their catastrophic uncoating. We will build on preliminary work suggesting that this exposes the viral genome, potentiating detection by nucleic acid sensors such as RIG-I and cGAS. Complement C3 is also capable of mediating immune responses once inside the cell but in a manner mechanistically distinct from antibodies. An important objective of this proposal will be to determine the cytosolic receptor for C3 and how it functions. Finally, we will exploit the assays we develop during these studies to investigate whether other pathogen-binding serum proteins possess intracellular activity.

View the original record at the funder ↗

Researchers

Leo James (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

'Trim-Away': Targeted Degradation of Proteins & Pathogens
Self-propagating protein conformations as targets of intracellular immunity
Characterization of Parp14-Trim25 directed mitochondrial ISGylation and its antagonism by viral deISGylases
Immunobiology Laboratory
Investigating the role of novel RNA-binding protein TRIM25 in viral nucleic acids sensing and signalling.

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.